Spyre Therapeutics
SYRE
SYRE
77 hedge funds and large institutions have $137M invested in Spyre Therapeutics in 2019 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 35 increasing their positions, 9 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
14% less capital invested
Capital invested by funds: $159M → $137M (-$21.9M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1K
Holders
77
Holding in Top 10
3
Calls
–
Puts
$1K
Top Buyers
| 1 | +$2.5M | |
| 2 | +$1.94M | |
| 3 | +$1.37M | |
| 4 |
AG
Artal Group
Luxembourg
|
+$1.16M |
| 5 |
State Street
Boston,
Massachusetts
|
+$954K |
Top Sellers
| 1 | -$6.25M | |
| 2 | -$5.4M | |
| 3 | -$2.19M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$611K |
| 5 |
MWNA
Marshall Wace North America
New York
|
-$179K |